Teladoc Health Q2 Revenue Misses, BetterHelp Cash-Pay Pressure Accelerates; Full-Year Guidance Cut Below Consensus
TDOC sits 59% above its 52-week low of $4.4.
Summary
Teladoc Health missed Q2 revenue estimates and cut full-year guidance below consensus as BetterHelp's cash-pay business deteriorated faster than expected. The company is accelerating its insurance rollout, but near-term revenue and profit headwinds persist.
Key Events · Earnings and Guidance · TDOC
-
Q2 Revenue Miss
Revenue of $606.9M fell 4% YoY, missing the year-ago $631.9M. BetterHelp segment revenue dropped 12% to $212.6M, driven by accelerating cash-pay declines.
-
Full-Year Guidance Cut Below Consensus
2026 revenue guidance lowered to $2.36B-$2.45B, below the $2.58B consensus. Adjusted EBITDA outlook of $271M-$303M implies margin compression.
-
BetterHelp Cash-Pay Pressure Accelerates
Cash-pay demand weakened further in late May and June, beyond prior assumptions. The company is accelerating insurance rollout, but near-term revenue and margins are under pressure.
-
Integrated Care Provides Offset
Integrated Care revenue grew 1% to $394.3M, with adjusted EBITDA margin expanding to 16.5% from 14.7% a year ago, partially offsetting BetterHelp weakness.
Analysis · TDOC · Industrial Applications And Services
Teladoc Health reported Q2 2026 revenue of $606.9 million, down 4% year-over-year and below the $631.9 million from a year ago. The BetterHelp segment saw a 12% revenue decline, with cash-pay demand weakening further in late May and June, forcing the company to lower its full-year revenue outlook to $2.36-$2.45 billion — well below the $2.58 billion consensus. Adjusted EBITDA also fell 5% to $65.7 million. While the Integrated Care segment grew 1% and expanded margins, the accelerating deterioration in BetterHelp's direct-to-consumer business raises concerns about the segment's ability to stabilize. The company is pivoting aggressively toward insurance-covered services, but near-term profitability is under pressure. The stock, already trading near multi-year lows, faces headwinds from both top-line contraction and execution risk in the insurance transition.
At the time of this filing, TDOC was trading at $7.01 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $4.40 to $9.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.